Read Anywhere and on Any Device!

Subscribe to Read | $0.00

Join today and start reading your favorite books for Free!

Create Free Account

Eu Competition Law and Pharmaceuticals

0/5 ( ratings)

This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.

The author team comprises academic experts and private practitioners who analyse recent case law at both EU and Member State levels - in the context of current issues and future trends, including those related to COVID-19 - and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.

Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law.

Format: Hardcover

Release: November 28, 2022

ISBN 13: 9781802204407

Eu Competition Law and Pharmaceuticals

0/5 ( ratings)

This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.

The author team comprises academic experts and private practitioners who analyse recent case law at both EU and Member State levels - in the context of current issues and future trends, including those related to COVID-19 - and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.

Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law.

Format: Hardcover

Release: November 28, 2022

ISBN 13: 9781802204407

More books from Wolf Sauter

EU Competition and Internal Market Law in the Health Care Sector

The Law and Policy of Healthcare Financing: An International Comparison of Models and Outcomes

Competition Law and Industrial Policy in the EU

Coherence in EU Competition Law

Public Services in EU Law

Healthcare Fraud, Corruption and Waste in Europe: National and Academic Perspectives

State and Market in European Union Law: The Public and Private Spheres of the Internal Market Before the Eu Courts

State and Market in European Union Law: The Public and Private Spheres of the Internal Market before the EU Courts (Cambridge Studies in European Law and Policy) by Wolf Sauter (2009-05-11)

Rate this book!

Write a review?